BIOMAT Database Logo BIOMAT Database Logo

Idiopathic granulomatous vasculitis: response to immunosuppressive therapy. 1995

G F Alguacil-Garcia, and J Moreno-Requena, and M Martinez-Albadalejo, and H Hallal-Hachem, and B Gonzalez-Pina, and M de Paco-Moya
Hospital Comarcal del Noroeste, Caravaca de la Cruz, Murcia, Spain.

A case of idiopathic granulomatous vasculitis (disseminated visceral giant cell arteritis) is described in an old woman, the seventh case of this rare disorder reported to date. The main organ affected was the liver and, to our knowledge, this is the first patient to be diagnosed while still alive and the only case to have received medical treatment. It is also the first time that muscular involvement has been documented in this condition. Cyclophosphamide treatment resulted in disappearance of symptoms and increase in weight. The patient died of an unrelated condition.

UI MeSH Term Description Entries
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D009135 Muscular Diseases Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE. Muscle Disorders,Myopathies,Myopathic Conditions,Muscle Disorder,Muscular Disease,Myopathic Condition,Myopathy
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013700 Giant Cell Arteritis A systemic autoimmune disorder that typically affects medium and large ARTERIES, usually leading to occlusive granulomatous vasculitis with transmural infiltrate containing multinucleated GIANT CELLS. The TEMPORAL ARTERY is commonly involved. This disorder appears primarily in people over the age of 50. Symptoms include FEVER; FATIGUE; HEADACHE; visual impairment; pain in the jaw and tongue; and aggravation of pain by cold temperatures. (From Adams et al., Principles of Neurology, 6th ed) Aortic Arteritis, Giant Cell,Aortitis, Giant Cell,Arteritis, Temporal,Cranial Arteritis,Horton Disease,Horton Giant Cell Arteritis,Juvenile Temporal Arteritis,Temporal Arteritis,Arteritis, Giant Cell, Horton,Arteritis, Giant Cell, Horton's,Giant Cell Aortic Arteritis,Giant Cell Aortitis,Giant Cell Aortitis, Horton's,Giant Cell Arteritis, Horton,Horton's Disease,Horton's Giant Cell Arteritis,Aortitides, Giant Cell,Arteritides, Cranial,Arteritides, Giant Cell,Arteritides, Juvenile Temporal,Arteritides, Temporal,Arteritis, Cranial,Arteritis, Giant Cell,Arteritis, Juvenile Temporal,Cranial Arteritides,Giant Cell Aortitides,Giant Cell Arteritides,Hortons Disease,Juvenile Temporal Arteritides,Temporal Arteritides,Temporal Arteritides, Juvenile,Temporal Arteritis, Juvenile

Related Publications

G F Alguacil-Garcia, and J Moreno-Requena, and M Martinez-Albadalejo, and H Hallal-Hachem, and B Gonzalez-Pina, and M de Paco-Moya
Pancytopenia in ANCA associated vasculitis: response to immunosuppressive therapy.
January 2003, Clinical and experimental rheumatology,
G F Alguacil-Garcia, and J Moreno-Requena, and M Martinez-Albadalejo, and H Hallal-Hachem, and B Gonzalez-Pina, and M de Paco-Moya
Immunosuppressive therapy for vasculitis.
January 1995, Current opinion in rheumatology,
G F Alguacil-Garcia, and J Moreno-Requena, and M Martinez-Albadalejo, and H Hallal-Hachem, and B Gonzalez-Pina, and M de Paco-Moya
Determinants of response to immunosuppressive therapy in idiopathic pulmonary fibrosis.
November 1994, The European respiratory journal,
G F Alguacil-Garcia, and J Moreno-Requena, and M Martinez-Albadalejo, and H Hallal-Hachem, and B Gonzalez-Pina, and M de Paco-Moya
Immunosuppressive therapy in cutaneous vasculitis.
January 1999, Clinics in dermatology,
G F Alguacil-Garcia, and J Moreno-Requena, and M Martinez-Albadalejo, and H Hallal-Hachem, and B Gonzalez-Pina, and M de Paco-Moya
Chronic immunosuppressive therapy for systemic vasculitis.
January 1997, Current opinion in rheumatology,
G F Alguacil-Garcia, and J Moreno-Requena, and M Martinez-Albadalejo, and H Hallal-Hachem, and B Gonzalez-Pina, and M de Paco-Moya
Granulomatous vasculitis.
April 2015, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia,
G F Alguacil-Garcia, and J Moreno-Requena, and M Martinez-Albadalejo, and H Hallal-Hachem, and B Gonzalez-Pina, and M de Paco-Moya
Granulomatous vasculitis.
June 1995, Seminars in respiratory infections,
G F Alguacil-Garcia, and J Moreno-Requena, and M Martinez-Albadalejo, and H Hallal-Hachem, and B Gonzalez-Pina, and M de Paco-Moya
[Granulomatous vasculitis].
January 1987, Phlebologie,
G F Alguacil-Garcia, and J Moreno-Requena, and M Martinez-Albadalejo, and H Hallal-Hachem, and B Gonzalez-Pina, and M de Paco-Moya
Granulomatous vasculitis.
June 1982, The New England journal of medicine,
G F Alguacil-Garcia, and J Moreno-Requena, and M Martinez-Albadalejo, and H Hallal-Hachem, and B Gonzalez-Pina, and M de Paco-Moya
Granulomatous Vasculitis.
July 2015, Dermatologic clinics,
Copied contents to your clipboard!